Supply of A high resolution mass spectrometer

The identification and validation of cancer biomarkers requires highly sensitive and robust analytical technologies capable of delivering deep proteome coverage, reproducible quantitation, and confident peptide and protein identification. To support ongoing research in the next generation diagnostic programme at CPI Biologics, Darlington, supporting application to clinical proteomics, there is a need to procure a LC-MS system specifically optimised for advanced proteomics applications. The LC-MS instrument will und...